BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 24180199)

  • 1. [Metformin, an antidiabetic molecule with anti-cancer properties].
    Beck E; Scheen AJ
    Rev Med Liege; 2013 Sep; 68(9):444-9. PubMed ID: 24180199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Which anti-tumour benefits to be expected from metformin?].
    Beck E; Scheen AJ
    Ann Endocrinol (Paris); 2013 May; 74(2):137-47. PubMed ID: 23566618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Anti-cancer activity of metformin: new perspectives for an old drug].
    Beck E; Scheen AJ
    Rev Med Suisse; 2010 Sep; 6(260):1601-7. PubMed ID: 20853715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin and cancer.
    Rizos CV; Elisaf MS
    Eur J Pharmacol; 2013 Apr; 705(1-3):96-108. PubMed ID: 23499688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticancer effects of metformin and its potential use as a therapeutic agent for breast cancer.
    Guppy A; Jamal-Hanjani M; Pickering L
    Future Oncol; 2011 Jun; 7(6):727-36. PubMed ID: 21675836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin in cancer.
    Mallik R; Chowdhury TA
    Diabetes Res Clin Pract; 2018 Sep; 143():409-419. PubMed ID: 29807101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New perspectives for metformin in cancer therapy].
    Loubière C; Dirat B; Tanti JF; Bost F
    Ann Endocrinol (Paris); 2013 May; 74(2):130-6. PubMed ID: 23587351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does use of metformin protect against cancer in Type 2 diabetes mellitus?
    Bo S; Benso A; Durazzo M; Ghigo E
    J Endocrinol Invest; 2012 Feb; 35(2):231-5. PubMed ID: 22490993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New clinical data with metformin therapy in patients with diabetes mellitus].
    Jermendy G
    Orv Hetil; 2010 Dec; 151(49):2025-30. PubMed ID: 21106483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of metformin on mortality following cancer among patients with diabetes.
    Lega IC; Shah PS; Margel D; Beyene J; Rochon PA; Lipscombe LL
    Cancer Epidemiol Biomarkers Prev; 2014 Oct; 23(10):1974-84. PubMed ID: 25030683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is it time to test metformin in breast cancer clinical trials?
    Cazzaniga M; Bonanni B; Guerrieri-Gonzaga A; Decensi A
    Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):701-5. PubMed ID: 19240238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metformin and sulfonylureas in relation to cancer risk in type II diabetes patients: a meta-analysis using primary data of published studies.
    Thakkar B; Aronis KN; Vamvini MT; Shields K; Mantzoros CS
    Metabolism; 2013 Jul; 62(7):922-34. PubMed ID: 23419783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer mortality reduction and metformin: a retrospective cohort study in type 2 diabetic patients.
    Bo S; Ciccone G; Rosato R; Villois P; Appendino G; Ghigo E; Grassi G
    Diabetes Obes Metab; 2012 Jan; 14(1):23-9. PubMed ID: 21812892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin in cancer treatment and prevention.
    Morales DR; Morris AD
    Annu Rev Med; 2015; 66():17-29. PubMed ID: 25386929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relation between diabetes, metformin treatment and the occurrence of malignancies in a Belgian primary care setting.
    Geraldine N; Marc A; Carla T; Chantal M; Stefaan B; Welcome W; Frank B
    Diabetes Res Clin Pract; 2012 Aug; 97(2):331-6. PubMed ID: 22386769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of metformin in early breast cancer: a modification of the traditional paradigm for clinical testing of anti-cancer agents.
    Goodwin PJ; Stambolic V; Lemieux J; Chen BE; Parulekar WR; Gelmon KA; Hershman DL; Hobday TJ; Ligibel JA; Mayer IA; Pritchard KI; Whelan TJ; Rastogi P; Shepherd LE
    Breast Cancer Res Treat; 2011 Feb; 126(1):215-20. PubMed ID: 20976543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin and cancer: licence to heal?
    Papanas N; Maltezos E; Mikhailidis DP
    Expert Opin Investig Drugs; 2010 Aug; 19(8):913-7. PubMed ID: 20557275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin: taking away the candy for cancer?
    Jalving M; Gietema JA; Lefrandt JD; de Jong S; Reyners AK; Gans RO; de Vries EG
    Eur J Cancer; 2010 Sep; 46(13):2369-80. PubMed ID: 20656475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin in Oncology - How Far Is Its Repurposing as an Anticancer Drug?
    Pácal L; Kaňková K
    Klin Onkol; 2020; 33(2):107-113. PubMed ID: 32303131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What every dentist should know about metformin, diabetes, and cancer.
    Frykenberg MR; Schneider A; Bashirelahi N
    Gen Dent; 2015; 63(5):70-2. PubMed ID: 26325646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.